Baird’s Global Healthcare team has completed over 225 healthcare M&A and financing transactions since 2017. The Baird team has advised public companies, private business owners and private equity sponsors on Healthcare M&A transactions worth in aggregate greater than $31 billion. Additionally, Baird’s Healthcare team has raised over $40 billion in capital for clients in over 145 initial public offerings, follow-on offerings and other financing transactions since 2016.

Baird's Global Investment Banking and Financial Sponsor coverage provide an extensive network of relationships among active Healthcare acquirers, partners and investors throughout the world. Our coverage spans several Healthcare sectors, including Biotechnology & Pharmaceuticals, Healthcare IT & Services, Life Sciences Tools & Diagnostics, Medical Technology, Pharmaceutical Services and Provider Services. Baird’s deep sector knowledge, frequent dialogue with key industry participants and investors, and robust deal flow provide us with unique insight into the sectors we serve

1014901-Biotech and Pharma-Final.jpg

1014901-Healthcare IT and Services-Final.jpg

1014901-Life Science Tools and Diagnostics-Final.jpg

1014901-Medical Tech-Final.jpg

1014901-Pharma Services-Final.jpg

1014901-Provider Services-Final.jpg